Buscar resultados de ensayos clínicos
Post-transplant Lymphoproliferative Disease - 10 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Fludarabine, Cyclophosphamide, Doxorubicin and Rituximab for the Treatment of Post-transplant Lymphoproliferative Disease (PTLD) Condición:
|
Recruiting |
Nombre del estudio: Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy Condición: Posttransplant Lymphoproliferative Disorder Fecha: 2014-01-20 Intervenciones:
|
Not yet recruiting |
Nombre del estudio: Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant Condición:
|
Recruiting |
Nombre del estudio: Phase II of Chemotherapy for Relapsed Epstein Barr Virus Associated Lymphoma Condición:
|
Terminated |
Nombre del estudio: Relationship Between EBV and PTLD Condición: Pediatric Heart Transplant Fecha: 2005-09-20 |
Terminated |
Nombre del estudio: Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation Condición: Lymphoproliferative Disorder Fecha: 2002-04-09 Intervenciones: Biological: therapeutic allogeneic lymphocytes |
Completed |
Nombre del estudio: Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder Condición:
Intervenciones: |
Terminated |
Nombre del estudio: Beta-Glucan and Rituximab in Treating Young Patients With Relapsed or Progressive Lymphoma or Leukemia, or Lymphoproliferative Disorder Related to Donor Stem Cell Transplantation Condición:
Fecha: 2004-07-08 Intervenciones:
|
Recruiting |
Nombre del estudio: Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive Cluster of Differentiation(CD) 20-Positive Post-Transplant Lymphoproliferative Disorder Condición:
|
Active, not recruiting |
Nombre del estudio: Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation Condición: Lymphoproliferative Disorder Fecha: 2003-08-06 Intervenciones:
|